CD40 and Patent ductus arteriosus: In this study, we used high-dimensional cellular phenotyping and plasma cytokine analysis to evaluate the immune response to a CD40 agonist in combination with gemcitabine chemotherapy in the peripheral blood of patients with advanced PDA.